This site is intended for health professionals only

Cardiovascular

VALIANT: valsartan in acute myocardial infarction trial
VALIANT: valsartan in acute myocardial infarction trial
Advances in venous thromboembolism
Advances in venous thromboembolism
Val-HeFT: the Valsartan Heart Failure Trial
Val-HeFT: the Valsartan Heart Failure Trial
Progress in hypertension diagnosis and treatment
Progress in hypertension diagnosis and treatment
Systolic hypertension: a treatment overview
Systolic hypertension: a treatment overview
DES in coronary atheromatous disease
DES in coronary atheromatous disease
POEM%: Simvastatin useful as primary prevention of CAD
POEM%: Simvastatin useful as primary prevention of CAD
Angiotensin blockers in diabetic nephropathy
Angiotensin blockers in diabetic nephropathy
POEM TM: ACE inhibitor better than diuretic in older men for hypertension
POEM TM: ACE inhibitor better than diuretic in older men for hypertension
Drug treatment for acute ischaemic stroke
Drug treatment for acute ischaemic stroke
Secondary prevention of myocardial infarction
Secondary prevention of myocardial infarction
Developing a guideline for severe pre-eclampsia
Developing a guideline for severe pre-eclampsia
1 … 67 68 69 70


Most read

1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
2
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
3
Oral vitamin A could become an alternative to isotretinoin for acne
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Pharmacy workforce: matching staffing resource to service demand 



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
×